← All organizations
Highest phase reached
Phase 1
First clinical trial
Dec 19, 2013Last known activity
May 9, 2018
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 2 trials)
Phase 1 (4 own, 0 via acquisition)
Indications
Studied for
- Breast Neoplasms
- Leukemia
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Myelodysplastic-Myeloproliferative Diseases
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Philadelphia Chromosome
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Recent trials (2)
- NCT03519984CollaboratorPhase 1May 9, 2018
- NCT02067884CollaboratorPhase 1Dec 19, 2013
Details
- Last known activity
- May 9, 2018